Drug recall · May 24, 2017
Milrinone Lactate in 5% Dextrose Injection recall
Why: Lack of assurance of sterility: customer complaints received for the presence of leaks.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-6010-48
- Lots / codes
Lot #: P342485, Exp 11/30/17; P344408, Exp 12/31/17
- Quantity
- 90,450 bags
- Company
- Baxter Healthcare Corporation, Deerfield, IL
- Distribution
- US and foreign countries: United Arab Emirates, Colombia, and Canada
- Initiated
- May 15, 2017 · Voluntary: Firm initiated
- Classified
- May 18, 2017
- Reported
- May 24, 2017
- Ended
- August 10, 2018
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lactate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.